Are flashcards effective for USMLE Step 3?

Yes. Flashcards use active recall — retrieving an answer from memory — which research shows is one of the most effective ways to make facts stick, especially in short sessions spread over several days. That helps with Step 3's rule-based recall (first-line therapies, drug monitoring, screening intervals, the sepsis bundle), freeing your effort for the clinical judgment the exam rewards.

What topics do the USMLE Step 3 flashcards cover?

The cards mirror Step 3's structure: exam format and the CCS, biostatistics and the medical literature, ethics, communication and patient safety, cardiovascular and respiratory management, renal, endocrine and GI management, acute and multisystem emergencies, the neuro/psych/OB-GYN/MSK/derm cluster, and nutrition and health maintenance — the management-focused content the final step tests.

Do these flashcards reflect what USMLE Step 3 actually tests?

Yes. Step 3 is the management exam — it rewards what you DO for the patient — so the cards emphasize first-line therapy, monitoring, best-next-step, screening and immunizations, and acute stabilization, plus the biostatistics and ethics that decide the Day 1 (FIP) items, all framed the way Step 3 tests them.

How should I study with these flashcards?

Mix the modes: flip to learn, type to test recall, match for speed, and quiz to check yourself. Weight your time toward management and biostatistics, turn the rule-based facts — drug monitoring, screening ages, the sepsis bundle, ethics principles — into instant recall, and pair the cards with timed practice questions and the CCS.

Are the USMLE Step 3 flashcards free?

Yes — 100% free, all four study modes, no paywall and no sign-up.

Is USMLE Step 3 scored or pass/fail?

Still SCORED — a three-digit numeric score (minimum 200 since Jan 1, 2024), unlike Step 1, which is now Pass/Fail only.

How many days is USMLE Step 3?

Two days, taken separately at a Prometric center: Day 1 (FIP) and Day 2 (ACM).

What is Day 1 of Step 3 called?

Foundations of Independent Practice (FIP).

What is Day 2 of Step 3 called?

Advanced Clinical Medicine (ACM).

Step 3 minimum passing score

200 on the three-digit scale (raised from 198, effective Jan 1, 2024).

Total questions on Step 3

About 412 multiple-choice questions plus roughly 13 computer-based case simulations (CCS).

Day 1 (FIP) structure

232 multiple-choice questions in 12 blocks of 30 minutes; about a 7-hour session.

Day 2 (ACM) structure

About 180 multiple-choice questions in 9 blocks plus about 13 CCS cases; about a 9-hour session.

Computer-based Case Simulation — an interactive patient-management format unique to Step 3 (Day 2); you manage a simulated patient over advancing clock time.

How many CCS cases on Step 3?

About 13 cases, each allotted up to 10 or 20 minutes of real time.

Does the CCS have answer choices?

No — there are no multiple-choice options; you type orders (history, exams, tests, treatments) and the patient evolves.

The free practice software from USMLE that mimics the CCS interface; practice it before exam day so mechanics never cost points.

Who registers candidates for Step 3?

The Federation of State Medical Boards (FSMB) is the registration entity for Step 3.

Must have passed Step 1 and Step 2 CK and hold an MD or DO degree; IMGs must also be ECFMG certified.

When do most people take Step 3?

During residency, often the intern (PGY-1) year.

What does Step 3 emphasize vs earlier Steps?

Patient MANAGEMENT and clinical decision-making for unsupervised practice — what you DO, not just what you know.

How is the Step 3 score combined?

Day 1 MCQ, Day 2 MCQ, and the CCS cases combine into one three-digit score and pass/fail outcome.

Step 3 first-time pass rate

Highest of the Steps (takers already passed 1 and 2 CK): roughly 98% US/Canadian MD, ~96% DO, ~88% international.

Percent correct needed to pass Step 3

Criterion-referenced; examinees generally need to answer about 60% of items correctly.

Maximum 4 attempts at any Step; no more than 3 within 12 months; a passed Step cannot be retaken.

Competency shift across USMLE

Step 1 = knowledge, Step 2 CK = diagnosis, Step 3 = management/decision-making.

Which Step has the CCS?

Only Step 3 (Day 2). Step 1 and Step 2 CK are multiple-choice only.

CCS scoring principle

Appropriate, timely, and safe management is rewarded; unnecessary, invasive, or risky orders are penalized — as in real care.

Biggest avoidable CCS mistake

Advancing the simulated clock on an unstable patient before treating the immediate threat.

Cases play out in the office, emergency department, and inpatient ward/ICU; you can move the patient between them.

Proportion of diseased who test positive (true-positive rate). A negative on a sensitive test rules OUT disease (SnNout).

Proportion of healthy who test negative (true-negative rate). A positive on a specific test rules IN disease (SpPin).

Positive predictive value (PPV)

Probability that a test-positive person truly has disease. Rises with prevalence.

Negative predictive value (NPV)

Probability that a test-negative person is truly disease-free. Falls with prevalence.

Do sensitivity/specificity change with prevalence?

No — they are intrinsic to the test. Predictive values DO change with prevalence.

Number needed to treat (NNT)

1 ÷ absolute risk reduction. Lower NNT = more effective treatment.

Number needed to harm (NNH)

1 ÷ absolute risk increase. Higher NNH = safer treatment.

Absolute risk reduction (ARR)

Risk in control group − risk in treatment group.

Risk in exposed ÷ risk in unexposed; derived from a cohort study.

Odds of exposure in cases ÷ odds in controls; from a case-control study. Approximates RR for rare outcomes.

Relative risk reduction (RRR)

1 − relative risk; the proportional reduction in risk from treatment.

Gold standard for causation

The randomized controlled trial (RCT).

Follows exposed vs unexposed forward in time; yields incidence and relative risk. Can be prospective or retrospective.

Compares cases (with disease) to controls (without) for past exposure; yields an odds ratio. Good for rare diseases.

Cross-sectional study

Measures exposure and disease at one point in time; yields prevalence. Cannot establish causation.

Incidence vs prevalence

Incidence = new cases over time; prevalence = existing cases at a point. Long-duration disease raises prevalence.

Rejecting a true null hypothesis — a false positive. Conventionally set at 0.05.

Failing to reject a false null hypothesis — a false negative.

Your FREE USMLE Step 3 Flashcards 2026 – 300+ Cards

Realistic, high-yield USMLE Step 3 flashcards — flip, match, type, and quiz yourself across patient management, biostatistics, ethics, the CCS format, and acute care.

Master cards to boost your scoreMaster cards to raise your exam readiness score

How well do you know them?

USMLE Step 3 Flashcards

Is USMLE Step 3 scored or pass/fail?: Still SCORED — a three-digit numeric score (minimum 200 since Jan 1, 2024), unlike Step 1, which is now Pass/Fail only.
How many days is USMLE Step 3?: Two days, taken separately at a Prometric center: Day 1 (FIP) and Day 2 (ACM).
What is Day 1 of Step 3 called?: Foundations of Independent Practice (FIP).
What is Day 2 of Step 3 called?: Advanced Clinical Medicine (ACM).
Step 3 minimum passing score: 200 on the three-digit scale (raised from 198, effective Jan 1, 2024).
Total questions on Step 3: About 412 multiple-choice questions plus roughly 13 computer-based case simulations (CCS).
Day 1 (FIP) structure: 232 multiple-choice questions in 12 blocks of 30 minutes; about a 7-hour session.
Day 2 (ACM) structure: About 180 multiple-choice questions in 9 blocks plus about 13 CCS cases; about a 9-hour session.
What is the CCS?: Computer-based Case Simulation — an interactive patient-management format unique to Step 3 (Day 2); you manage a simulated patient over advancing clock time.
How many CCS cases on Step 3?: About 13 cases, each allotted up to 10 or 20 minutes of real time.
Does the CCS have answer choices?: No — there are no multiple-choice options; you type orders (history, exams, tests, treatments) and the patient evolves.
Primum CCS software: The free practice software from USMLE that mimics the CCS interface; practice it before exam day so mechanics never cost points.
Who registers candidates for Step 3?: The Federation of State Medical Boards (FSMB) is the registration entity for Step 3.
Step 3 eligibility: Must have passed Step 1 and Step 2 CK and hold an MD or DO degree; IMGs must also be ECFMG certified.
When do most people take Step 3?: During residency, often the intern (PGY-1) year.
What does Step 3 emphasize vs earlier Steps?: Patient MANAGEMENT and clinical decision-making for unsupervised practice — what you DO, not just what you know.
How is the Step 3 score combined?: Day 1 MCQ, Day 2 MCQ, and the CCS cases combine into one three-digit score and pass/fail outcome.
Step 3 first-time pass rate: Highest of the Steps (takers already passed 1 and 2 CK): roughly 98% US/Canadian MD, ~96% DO, ~88% international.
Percent correct needed to pass Step 3: Criterion-referenced; examinees generally need to answer about 60% of items correctly.
Step 3 attempt limit: Maximum 4 attempts at any Step; no more than 3 within 12 months; a passed Step cannot be retaken.
Competency shift across USMLE: Step 1 = knowledge, Step 2 CK = diagnosis, Step 3 = management/decision-making.
Which Step has the CCS?: Only Step 3 (Day 2). Step 1 and Step 2 CK are multiple-choice only.
CCS scoring principle: Appropriate, timely, and safe management is rewarded; unnecessary, invasive, or risky orders are penalized — as in real care.
Biggest avoidable CCS mistake: Advancing the simulated clock on an unstable patient before treating the immediate threat.
Step 3 care settings: Cases play out in the office, emergency department, and inpatient ward/ICU; you can move the patient between them.
Sensitivity: Proportion of diseased who test positive (true-positive rate). A negative on a sensitive test rules OUT disease (SnNout).
Specificity: Proportion of healthy who test negative (true-negative rate). A positive on a specific test rules IN disease (SpPin).
False-negative rate: 1 − sensitivity.
False-positive rate: 1 − specificity.
Positive predictive value (PPV): Probability that a test-positive person truly has disease. Rises with prevalence.
Negative predictive value (NPV): Probability that a test-negative person is truly disease-free. Falls with prevalence.
Do sensitivity/specificity change with prevalence?: No — they are intrinsic to the test. Predictive values DO change with prevalence.
Number needed to treat (NNT): 1 ÷ absolute risk reduction. Lower NNT = more effective treatment.
Number needed to harm (NNH): 1 ÷ absolute risk increase. Higher NNH = safer treatment.
Absolute risk reduction (ARR): Risk in control group − risk in treatment group.
Relative risk (RR): Risk in exposed ÷ risk in unexposed; derived from a cohort study.
Odds ratio (OR): Odds of exposure in cases ÷ odds in controls; from a case-control study. Approximates RR for rare outcomes.
Relative risk reduction (RRR): 1 − relative risk; the proportional reduction in risk from treatment.
Gold standard for causation: The randomized controlled trial (RCT).
Cohort study: Follows exposed vs unexposed forward in time; yields incidence and relative risk. Can be prospective or retrospective.
Case-control study: Compares cases (with disease) to controls (without) for past exposure; yields an odds ratio. Good for rare diseases.
Cross-sectional study: Measures exposure and disease at one point in time; yields prevalence. Cannot establish causation.
Incidence vs prevalence: Incidence = new cases over time; prevalence = existing cases at a point. Long-duration disease raises prevalence.
Type I error (alpha): Rejecting a true null hypothesis — a false positive. Conventionally set at 0.05.
Type II error (beta): Failing to reject a false null hypothesis — a false negative.
Statistical power: 1 − beta; the probability of detecting a true effect. Increases with larger sample size and effect size.
p-value: Probability of obtaining the observed result (or more extreme) if the null hypothesis were true; <0.05 is conventionally significant.
95% confidence interval (for a ratio): If it crosses 1.0 (RR/OR) the result is not statistically significant; for a difference, crossing 0 means not significant.
Likelihood ratio positive: Sensitivity ÷ (1 − specificity); independent of prevalence. >10 strongly raises post-test probability.
Selection bias: Systematic error from how subjects are chosen (e.g., Berkson bias, healthy-worker effect).
Recall bias: Cases remember exposures differently from controls; classic in case-control studies.
Lead-time bias: Screening detects disease earlier, falsely lengthening apparent survival without changing outcome.
Length-time bias: Screening preferentially detects slow, indolent disease, overstating screening benefit.
Confounding: A third variable associated with both exposure and outcome that distorts the association; control by randomization, matching, or stratification.
Effect modification: The effect of an exposure differs across levels of a third variable (a real finding, reported by subgroup — not a bias to eliminate).
Intention-to-treat analysis: Analyze participants in their assigned group regardless of adherence; preserves randomization and reduces bias.
Number to screen: More patients must be screened than treated to prevent one outcome; NNT contextualizes screening benefit.
Mean vs median vs mode: Mean = average (sensitive to outliers); median = middle value (robust); mode = most frequent value.
Positively (right) skewed distribution: Tail to the right; mean > median > mode (e.g., income, length of stay).
Standard error of the mean: Standard deviation ÷ √n; shrinks as sample size grows.
Sensitivity vs specificity trade-off: Lowering a test threshold raises sensitivity but lowers specificity, and vice versa (ROC curve).
Pretest probability: Estimated likelihood of disease before testing; combined with likelihood ratios to get post-test probability.
Hazard ratio: Compares the rate of an event over time between groups in survival analysis; like RR but accounts for time.
Meta-analysis: Pools results from multiple studies for greater power; quality depends on the included studies (garbage in, garbage out).
Systematic review vs narrative review: Systematic uses explicit, reproducible methods to find and appraise all evidence; narrative is expert opinion-driven.
External vs internal validity: Internal = results are correct for the study sample; external (generalizability) = results apply to other populations.
Screening test choice: Prefer a HIGH-sensitivity test to screen (few false negatives); confirm a positive with a HIGH-specificity test.
Crude vs adjusted analysis: Adjusted analysis accounts for confounders; a large change between crude and adjusted estimates suggests confounding.
Publication bias: Positive studies are more likely to be published, biasing meta-analyses; assessed with a funnel plot.
Kaplan-Meier curve: Plots survival probability over time; the log-rank test compares two survival curves.
Four principles of medical ethics: Autonomy, beneficence, non-maleficence, and justice.
Elements of informed consent: Capacity, disclosure (diagnosis, intervention, risks, benefits, alternatives), understanding, and voluntariness.
Capacity vs competency: Capacity is a clinical, decision-specific judgment by a physician; competency is a global legal determination by a court.
Can a patient with capacity refuse life-saving care?: Yes — respecting autonomy, a capacitated patient may refuse even life-saving treatment.
Exceptions to informed consent: Emergencies, waiver by the patient, therapeutic privilege, and care of a patient who lacks capacity (use surrogate/advance directive).
Minor consent exceptions: Minors can often consent for emergencies, STIs, contraception, pregnancy, substance use, and if emancipated.
Advance directive: A patient's prior instructions (living will) or designated proxy guiding care when they lack capacity.
Substituted judgment: A surrogate decides what the patient WOULD have wanted, not what the surrogate prefers.
Surrogate decision-maker order: Typically: healthcare proxy/POA, then spouse, adult children, parents, siblings (varies by state).
Disclosing a medical error: Disclose honestly and promptly to the patient; transparency is ethically required even if no harm occurred.
Confidentiality and its limits: Maintain confidentiality except for reportable conditions, threats to others (Tarasoff), child/elder abuse, and certain infections.
Duty to warn (Tarasoff): A clinician may have a duty to protect an identifiable third party from a serious, credible threat by a patient.
Best response on an ethics item: The option that talks WITH the patient — explore concerns, give honest information, respect a capacitated choice; avoid paternalism/deception.
Patient who refuses recommended care: Assess capacity, explore reasons, educate, and ultimately respect a capacitated refusal — document the discussion.
Decisional capacity criteria: Understand the information, appreciate it applies to them, reason about options, and communicate a consistent choice.
Emancipated minor: A minor who is married, in the military, financially independent, or court-declared; can consent like an adult.
Withholding vs withdrawing care: Ethically and legally equivalent; both are permissible at a capacitated patient's or surrogate's direction.
Futile treatment: Physicians are not obligated to provide care that cannot achieve its goal; communicate compassionately and involve ethics consult if needed.
Beneficence vs autonomy conflict: When they conflict, a capacitated patient's autonomous, informed choice generally prevails.
Gifts from patients / industry: Decline gifts that could impair judgment or create conflicts of interest; disclose relevant conflicts.
Impaired colleague: Report a colleague impaired by substances or illness to protect patients (to the supervisor or physician health program).
Breaking bad news: Use a stepwise approach (e.g., SPIKES): private setting, assess understanding, deliver clearly, respond to emotion, plan.
Motivational interviewing: A patient-centered counseling style that elicits the patient's own motivation to change behavior.
Swiss-cheese model: Accidents happen when latent system weaknesses (holes) line up; layered defenses prevent most errors.
Active vs latent error: Active = at the sharp end (the person doing the task); latent = system/design failures upstream.
Root-cause analysis (RCA): A retrospective, systematic review of an adverse event to find and fix underlying causes.
Failure mode and effects analysis (FMEA): A prospective method to anticipate and prevent failures in a process before they occur.
Near miss vs adverse event vs sentinel event: Near miss = reaches no patient; adverse event = causes harm; sentinel event = serious, reportable harm.
Just culture: Distinguishes blameless human error from reckless behavior; encourages reporting without punishing honest mistakes.
Forcing function: A design that prevents an error (e.g., a connector that only fits the correct port); a strong system safeguard.
Highest-reliability error prevention: System fixes (forcing functions, checklists, CPOE with decision support) beat reminders, education, or blaming individuals.
Computerized provider order entry (CPOE): Reduces transcription and dosing errors, especially with clinical decision support.
Time-out before surgery: A team pause to confirm correct patient, procedure, and site — prevents wrong-site surgery.
Quality improvement (PDSA cycle): Plan-Do-Study-Act: small, iterative tests of change to improve a process.
Informed refusal: Documenting that a capacitated patient declined a recommended intervention after understanding the risks.
Hypertension first-line drugs: Thiazide diuretic, ACE inhibitor or ARB, or calcium channel blocker (CCB).
Hypertension in diabetes with albuminuria: Prefer an ACE inhibitor or ARB (renoprotective).
Stage 1 vs stage 2 hypertension: Stage 1: 130-139/80-89 mmHg; Stage 2: ≥140/90 mmHg (confirm with repeat/out-of-office readings).
Hypertensive emergency: Severe BP elevation with end-organ damage; lower BP with IV agents, by ≈10-20% in the first hour (avoid overcorrection).
Atrial fibrillation rate control: Beta-blocker or non-dihydropyridine CCB (diltiazem, verapamil) for most patients.
Anticoagulation in atrial fibrillation: Guided by the CHA2DS2-VASc score; higher score favors oral anticoagulation to prevent embolic stroke.
Unstable atrial fibrillation: Immediate synchronized cardioversion (hypotension, chest pain, heart failure, altered mentation).
CHA2DS2-VASc components: CHF, Hypertension, Age ≥75 (2), Diabetes, Stroke/TIA (2), Vascular disease, Age 65-74, Sex category (female).
HFrEF guideline-directed therapy: ARNI (or ACE inhibitor/ARB) + beta-blocker + aldosterone antagonist + SGLT2 inhibitor; add a loop diuretic for congestion.
Drugs that reduce mortality in HFrEF: Beta-blockers, ACE inhibitor/ARB/ARNI, aldosterone antagonists, SGLT2 inhibitors, and hydralazine-nitrate in select patients.
Acute decompensated heart failure: Oxygen, IV loop diuretic, and vasodilators (nitroglycerin) if hypertensive; treat the precipitant.
STEMI management: Aspirin + ECG immediately, then reperfusion — PCI within 90 minutes (or fibrinolysis if PCI unavailable).
Acute coronary syndrome initial meds: Aspirin, oxygen if hypoxic, nitroglycerin, and anticoagulation; add a P2Y12 inhibitor and statin.
Stable angina management: Antianginals (beta-blocker, nitrates, CCB) plus risk-factor control (aspirin, statin, BP, smoking cessation).
Statin indications: Clinical ASCVD, LDL ≥190, diabetes age 40-75, or elevated 10-year ASCVD risk; high-intensity for ASCVD.
Statin monitoring/adverse effects: Myopathy/rhabdomyolysis and transaminase elevation; check a baseline lipid panel and address muscle symptoms.
Bradycardia / symptomatic AV block: Atropine first; transcutaneous pacing if refractory; pacemaker for high-grade block.
Stable ventricular tachycardia: Antiarrhythmics (amiodarone, procainamide); cardiovert if unstable; defibrillate pulseless VT/VF.
Amiodarone toxicities: Thyroid (hypo- or hyper-), pulmonary fibrosis, hepatotoxicity, corneal deposits, blue-gray skin; monitor TFTs, LFTs, PFTs.
Warfarin monitoring: INR (target 2-3 for most indications, 2.5-3.5 for mechanical mitral valves).
Heparin (unfractionated) monitoring: aPTT (or anti-Xa); reverse with protamine.
Aortic stenosis: Harsh crescendo-decrescendo systolic murmur radiating to carotids; symptoms (angina, syncope, dyspnea) → valve replacement.
Infective endocarditis: Fever + new murmur; obtain blood cultures and echo; empiric antibiotics then tailor; surgery for complications.
Pericarditis: Pleuritic chest pain better leaning forward, diffuse ST elevation; treat with NSAIDs + colchicine.
DVT prophylaxis in hospitalized patients: Pharmacologic (LMWH/heparin) or mechanical prophylaxis based on risk; a high-yield CCS order.
COPD exacerbation management: Inhaled short-acting bronchodilators, systemic corticosteroids, antibiotics if purulent sputum; controlled oxygen (SpO2 88-92%).
Why limit oxygen in COPD?: Over-oxygenation can blunt respiratory drive and worsen CO2 retention; target SpO2 88-92%.
COPD maintenance therapy: Inhaled long-acting bronchodilators (LABA/LAMA), inhaled steroids in select patients, smoking cessation, pulmonary rehab, vaccines.
Asthma exacerbation: Inhaled short-acting beta-agonist + ipratropium, systemic steroids, oxygen; assess severity and response.
Asthma stepwise control: Inhaled corticosteroid is the controller backbone; step up with LABA; reassess control and technique.
Obstructive vs restrictive PFTs: Obstructive: low FEV1/FVC ratio (asthma, COPD). Restrictive: normal/high ratio with low volumes (fibrosis).
Pulmonary embolism diagnosis: Risk-stratify (Wells); D-dimer if low probability, CT pulmonary angiography if higher; treat with anticoagulation.
Massive PE with hemodynamic instability: Consider systemic thrombolysis (or embolectomy) in addition to anticoagulation.
Community-acquired pneumonia (outpatient): Empiric amoxicillin or doxycycline (or a macrolide); a respiratory fluoroquinolone if comorbidities.
CAP requiring admission: Beta-lactam plus a macrolide, or a respiratory fluoroquinolone; use severity scores (CURB-65) to guide site of care.
Pleural effusion workup: Thoracentesis with Light's criteria to classify transudate vs exudate.
Spontaneous pneumothorax management: Small and stable: observation with oxygen. Large or symptomatic: needle aspiration or chest tube; recurrence may need pleurodesis.
Smoking cessation pharmacotherapy: Varenicline (most effective), bupropion, and nicotine replacement; combine with counseling.
Hyperlipidemia lifestyle + drug: Diet, exercise, weight loss first; statin is first-line drug; ezetimibe or PCSK9 inhibitor if goals unmet.
Hypertensive disorder workup: Confirm with repeated proper measurements; screen for secondary causes if young, severe, or resistant.
Resistant hypertension: Uncontrolled on 3 drugs (incl. a diuretic); add spironolactone and evaluate for secondary causes (e.g., primary aldosteronism).
Syncope red flags: Exertional syncope, family history of sudden death, abnormal ECG → cardiac workup (structural/arrhythmic cause).
Aspirin for primary prevention: No longer routine for most adults; individualize based on ASCVD risk and bleeding risk (favor in selected 40-59-year-olds).
Beta-blocker contraindication in heart failure: Avoid initiating during acute decompensation; start once euvolemic and stable.
ACE inhibitor cough vs ARB: ACE inhibitors cause cough/angioedema via bradykinin; switch to an ARB if cough is intolerable.
New oxygen requirement on the ward: Reassess for PE, pneumonia, fluid overload, or pneumothorax; a common CCS reassessment trigger.
Atrial flutter management: Rate control and anticoagulation like atrial fibrillation; consider cavotricuspid isthmus ablation (often curative).
Hypertrophic cardiomyopathy: Murmur ↑ with Valsalva; avoid dehydration and high-intensity competitive sport; beta-blockers; screen relatives.
Cardiac stress test indication: Stable chest pain with intermediate pretest probability; choose imaging stress if the ECG is uninterpretable.
Type 2 diabetes first-line drug: Metformin (plus lifestyle).
Diabetes drugs with CV/renal benefit: SGLT2 inhibitors and GLP-1 receptor agonists; add for atherosclerotic disease, heart failure, or chronic kidney disease.
HbA1c diagnostic threshold: ≥6.5% diagnoses diabetes (or fasting glucose ≥126, 2-hour OGTT ≥200, or random ≥200 with symptoms).
Diabetes glycemic target: HbA1c <7% for most adults; individualize (looser in frail/elderly, tighter in young/healthy).
Metformin contraindications: Avoid in significant renal impairment (eGFR <30) and around iodinated contrast; risk of lactic acidosis.
Diabetic kidney disease screening: Annual urine albumin-to-creatinine ratio and eGFR; treat with an ACE inhibitor/ARB and an SGLT2 inhibitor.
Hypothyroidism treatment: Levothyroxine; titrate to a normal TSH; recheck TSH about every 6 weeks after dose changes.
Hyperthyroidism (Graves) options: Methimazole, radioactive iodine, or surgery; beta-blocker for symptoms.
Subclinical hypothyroidism: Elevated TSH with normal free T4; treat if TSH >10, symptomatic, or pregnant/planning pregnancy.
Thyroid nodule workup: TSH and ultrasound; fine-needle aspiration based on size and sonographic risk features.
Primary adrenal insufficiency (Addison): Low cortisol with high ACTH; hyperpigmentation, hyperkalemia, hyponatremia; treat with hydrocortisone + fludrocortisone.
Cushing syndrome workup: Confirm hypercortisolism (24-hour urine cortisol, late-night salivary cortisol, dexamethasone suppression), then find the source.
Primary aldosteronism: Hypertension with hypokalemia; elevated aldosterone-to-renin ratio; consider in resistant hypertension.
Hyperkalemia management: Calcium gluconate (cardioprotection), insulin + glucose and beta-agonist (shift), then removal (diuretics, dialysis, binders).
ECG of hyperkalemia: Peaked T waves → widened QRS → sine wave; give IV calcium immediately to stabilize the membrane.
Hyponatremia approach: Assess volume status and serum osmolality; correct slowly (≤8 mEq/L per 24 h) to avoid osmotic demyelination.
SIADH: Euvolemic hyponatremia with concentrated urine; treat with fluid restriction; identify the cause (drugs, lung/CNS disease).
Acute kidney injury — prerenal: Low perfusion (volume loss, heart failure); BUN/Cr >20, FENa <1%; treat the underlying cause and restore volume.
Acute kidney injury — intrinsic (ATN): Tubular injury (ischemia, contrast, drugs); muddy-brown casts, FENa >2%; supportive care and remove the insult.
Postrenal AKI: Obstruction (e.g., BPH, stones); diagnose with bladder scan/ultrasound; relieve the obstruction (catheter, stent).
Chronic kidney disease management: Control BP and glucose, ACE inhibitor/ARB and SGLT2 inhibitor, manage anemia/bone disease, avoid nephrotoxins.
Indications for urgent dialysis (AEIOU): Acidosis, Electrolytes (refractory hyperkalemia), Intoxications, Overload (fluid), Uremia (pericarditis, encephalopathy).
Nephrolithiasis acute care: Analgesia (NSAIDs), hydration, and antiemetics; stones <5 mm usually pass; alpha-blocker for medical expulsive therapy.
UTI in nonpregnant woman: Uncomplicated cystitis: nitrofurantoin, TMP-SMX, or fosfomycin; treat pyelonephritis with fluoroquinolone or ceftriaxone.
Asymptomatic bacteriuria treatment: Treat only in pregnancy or before urologic procedures; otherwise do not treat.
GERD management: Lifestyle changes and a proton pump inhibitor; alarm features (dysphagia, weight loss, bleeding) → endoscopy.
Peptic ulcer disease: Test and treat H. pylori; stop NSAIDs; PPI therapy; endoscopy for bleeding or alarm features.
Upper GI bleed initial care: Two large-bore IVs, fluids/blood, IV PPI, and urgent endoscopy; octreotide and antibiotics if variceal.
C. difficile infection: Stop the offending antibiotic; treat with oral vancomycin or fidaxomicin (not metronidazole first-line now).
Acute pancreatitis: Diagnose with lipase + clinical/imaging; treat with IV fluids, analgesia, and early enteral nutrition; find the cause (gallstones, alcohol).
Cirrhosis complications: Ascites (diuretics, paracentesis), variceal bleeding (banding, beta-blocker), SBP (antibiotics), encephalopathy (lactulose).
Spontaneous bacterial peritonitis: Ascitic fluid neutrophils ≥250/mm3; treat with cefotaxime; add albumin to reduce renal injury.
Hepatic encephalopathy: Treat with lactulose (and rifaximin); identify precipitants (GI bleed, infection, electrolyte derangement).
Inflammatory bowel disease flare: 5-ASA, corticosteroids for flares, and steroid-sparing agents (immunomodulators, biologics) for maintenance.
Diverticulitis (uncomplicated): Often managed with antibiotics (or supportive care in mild cases); colonoscopy after resolution to exclude malignancy.
Hypercalcemia (most common cause): Primary hyperparathyroidism (outpatient) and malignancy (inpatient); treat severe cases with IV fluids then bisphosphonates.
Osteoporosis treatment: Bisphosphonates first-line; ensure adequate calcium and vitamin D; consider denosumab or anabolic agents in high risk.
Diabetes foot/eye care: Annual dilated retinal exam and comprehensive foot exam; daily foot inspection — a continued-care health-maintenance staple.
Insulin regimen basics: Basal-bolus mimics physiology; check potassium and renal function; insulin shifts potassium into cells.
Pheochromocytoma: Episodic hypertension, headache, palpitations, sweating; alpha-blockade BEFORE beta-blockade, then surgery.
Hypomagnesemia: Causes refractory hypokalemia and hypocalcemia; replace magnesium to correct them.
Metabolic acidosis approach: Calculate the anion gap; high gap = MUDPILES; normal gap = bicarbonate loss (diarrhea, RTA).
Vancomycin monitoring: Trough levels (or AUC) and renal function; risk of nephrotoxicity.
Contrast-induced nephropathy prevention: Hydration and minimizing contrast in at-risk patients (CKD, diabetes); hold nephrotoxins.
Sepsis early bundle: Blood cultures and lactate, broad-spectrum antibiotics within 1 hour, and IV crystalloid resuscitation.
Septic shock vasopressor: Norepinephrine is first-line if hypotension persists after fluid resuscitation.
Don't delay antibiotics in sepsis: Give antibiotics promptly after drawing cultures — early antibiotics save lives.
Lactate in sepsis: A rising lactate signals tissue hypoperfusion; trend it to assess resuscitation response.
DKA management: IV fluids, insulin infusion, and potassium repletion; treat the precipitant; close the anion gap before SC insulin.
Why check potassium before insulin in DKA?: Insulin drives potassium into cells; giving it when potassium is low can cause fatal hypokalemia.
Hyperosmolar hyperglycemic state: Profound hyperglycemia with severe dehydration, minimal ketosis; aggressive fluids, insulin, electrolytes.
Anaphylaxis first action: Intramuscular epinephrine — before antihistamines or steroids; also airway, oxygen, IV fluids.
Acute ischemic stroke: Non-contrast CT to exclude bleed; tPA within window if eligible; thrombectomy for large-vessel occlusion; control glucose/BP.
Stroke blood pressure (for tPA): Lower to <185/110 before thrombolysis; otherwise permissive hypertension in ischemic stroke.
Status epilepticus: ABCs and glucose; benzodiazepine first (lorazepam), then a second-line agent (levetiracetam, fosphenytoin, valproate).
GI bleed resuscitation: Two large-bore IVs, fluids and blood products, reverse coagulopathy, and urgent endoscopy.
Acute respiratory failure: Support oxygenation/ventilation (NIV or intubation), identify cause; ARDS uses low-tidal-volume lung-protective ventilation.
Tension pneumothorax: Needle decompression then chest tube immediately — clinical diagnosis, do not wait for imaging.
Acute coronary syndrome (unstable): Aspirin + ECG now; reperfuse STEMI; anticoagulate; manage arrhythmia and hemodynamics.
Massive PE: Anticoagulation plus systemic thrombolysis (or embolectomy) if hemodynamically unstable.
Acetaminophen overdose antidote: N-acetylcysteine (use the nomogram to time-stratify); prevents NAPQI-mediated hepatotoxicity.
Opioid overdose antidote: Naloxone; support ventilation; repeat dosing as needed due to short half-life.
Benzodiazepine overdose: Supportive care; flumazenil rarely used (can precipitate seizures, especially in chronic users).
Salicylate toxicity: Mixed respiratory alkalosis and anion-gap metabolic acidosis; alkalinize urine; dialysis if severe.
Carbon monoxide poisoning: 100% oxygen (hyperbaric in severe cases); pulse oximetry is falsely normal — check carboxyhemoglobin.
Tricyclic antidepressant overdose: Wide QRS and arrhythmia; give IV sodium bicarbonate.
Beta-blocker / CCB overdose: Bradycardia and hypotension; treat with calcium, glucagon, high-dose insulin-euglycemia therapy.
Methanol/ethylene glycol poisoning: Anion-gap acidosis; treat with fomepizole and dialysis.
Organophosphate poisoning: Cholinergic toxidrome (SLUDGE); treat with atropine and pralidoxime.
Hyperkalemia emergency: IV calcium first (membrane stabilization), then insulin/glucose and beta-agonist to shift, then removal.
Massive transfusion complications: Hypocalcemia (citrate), hyperkalemia, hypothermia, and coagulopathy; warm products and monitor electrolytes.
Neutropenic fever: Medical emergency; obtain cultures and start empiric broad-spectrum antibiotics (antipseudomonal) immediately.
Tumor lysis syndrome: Hyperkalemia, hyperphosphatemia, hyperuricemia, hypocalcemia; hydration, allopurinol or rasburicase, monitor electrolytes.
DIC: Consumption of clotting factors and platelets; treat the underlying cause; replace products if bleeding.
Adrenal (addisonian) crisis: Hypotension and shock; give IV hydrocortisone and aggressive fluids immediately — do not wait for testing.
Thyroid storm: Fever, tachycardia, agitation; beta-blocker, thionamide, iodine (after thionamide), and steroids.
Myxedema coma: Severe hypothyroidism with hypothermia and altered mental status; IV levothyroxine and stress-dose steroids.
Hypertensive emergency target: Lower BP gradually (about 10-20% in the first hour) with IV agents to avoid hypoperfusion.
Acute limb ischemia: 6 Ps (pain, pallor, pulselessness, paresthesia, poikilothermia, paralysis); anticoagulate and revascularize urgently.
Compartment syndrome: Pain out of proportion, pain on passive stretch; emergent fasciotomy — do not wait for pulselessness.
Necrotizing fasciitis: Severe pain, rapid spread, crepitus; emergent surgical debridement plus broad-spectrum antibiotics.
Acute angle-closure glaucoma: Painful red eye, mid-dilated fixed pupil, vision loss; lower IOP urgently; ophthalmology emergency.
Septic arthritis: Joint aspiration before antibiotics; empiric antibiotics and drainage to prevent joint destruction.
Meningitis empiric therapy: Vancomycin + ceftriaxone (+ ampicillin if Listeria risk); add dexamethasone; do not delay antibiotics for imaging/LP.
Major depressive disorder first-line: SSRIs (with psychotherapy); allow several weeks for effect; assess suicide risk.
Suicide risk assessment: Ask directly about ideation, plan, intent, and means; ensure safety; hospitalize if high risk.
Serotonin syndrome: Agitation, hyperreflexia, clonus, hyperthermia from serotonergic drugs; stop the agent, supportive care, cyproheptadine.
Neuroleptic malignant syndrome: Rigidity, hyperthermia, autonomic instability from antipsychotics; stop the drug, cool, dantrolene/bromocriptine.
Bipolar disorder maintenance: Mood stabilizers (lithium, valproate) or atypical antipsychotics; avoid antidepressant monotherapy (mania risk).
Lithium monitoring/toxicity: Narrow therapeutic index; monitor levels, renal and thyroid function; tremor, ataxia, and confusion signal toxicity.
Generalized anxiety disorder: First-line SSRIs/SNRIs and CBT; avoid long-term benzodiazepines.
Alcohol withdrawal: Benzodiazepines (symptom-triggered); thiamine before glucose; watch for delirium tremens.
Wernicke encephalopathy: Confusion, ataxia, ophthalmoplegia from thiamine deficiency; give IV thiamine BEFORE glucose.
Opioid use disorder treatment: Medication-assisted treatment: buprenorphine, methadone, or naltrexone, with counseling.
ADHD treatment: Stimulants (methylphenidate, amphetamines) are first-line; behavioral therapy in young children.
Antipsychotic metabolic monitoring: Atypicals cause weight gain, dyslipidemia, and diabetes; monitor weight, glucose, and lipids.
Dementia (Alzheimer) treatment: Cholinesterase inhibitors and memantine modestly help; address safety, caregivers, and reversible causes.
Delirium management: Identify and treat the underlying cause; reorient and avoid restraints; use antipsychotics sparingly for severe agitation.
Parkinson disease treatment: Carbidopa-levodopa for symptomatic motor disease; dopamine agonists in younger patients.
Migraine treatment: Acute: triptans and NSAIDs; prophylaxis (frequent attacks): beta-blockers, topiramate, or CGRP antagonists.
Seizure first unprovoked: Evaluate with EEG and MRI; antiepileptic therapy based on seizure type and recurrence risk.
Bell palsy: Acute peripheral facial nerve palsy (forehead involved); treat with corticosteroids (± antivirals); eye protection.
Multiple sclerosis: Relapsing neuro deficits separated in time and space; acute relapse → steroids; disease-modifying therapy long-term.
Guillain-Barre syndrome: Ascending paralysis and areflexia; treat with IVIG or plasmapheresis; monitor respiratory status.
TIA workup: Urgent evaluation (ABCD2), neuroimaging, carotid and cardiac assessment; start antiplatelet and statin.
Prenatal first-visit labs: Blood type/Rh, CBC, rubella, HIV, hepatitis B, syphilis, urine culture, and Pap as indicated.
Folic acid in pregnancy: Start 0.4 mg daily before conception (higher if prior neural tube defect) to prevent neural tube defects.
Gestational diabetes screening: Screen at 24-28 weeks with a glucose challenge; manage with diet, then insulin if needed.
Preeclampsia: New hypertension + proteinuria (or end-organ signs) after 20 weeks; magnesium sulfate for seizure prophylaxis; deliver definitively.
Eclampsia management: Magnesium sulfate to control/prevent seizures, blood pressure control, and delivery.
Rh-negative mother: Give anti-D immune globulin (RhoGAM) at 28 weeks and after delivery of an Rh-positive infant.
Ectopic pregnancy: Positive pregnancy test with adnexal pain/bleeding; methotrexate if stable/criteria met, surgery if ruptured/unstable.
Postpartum hemorrhage: Most commonly uterine atony; fundal massage, uterotonics (oxytocin), and escalate to procedures if needed.
Contraception for the postpartum patient: Progestin-only methods are preferred while breastfeeding; avoid estrogen early postpartum (VTE risk).
Cervical cancer screening: Begin at age 21; cytology every 3 years, or co-testing/HPV testing per guidelines from age 25-30.
Abnormal uterine bleeding workup: Exclude pregnancy; evaluate structural and hormonal causes; endometrial biopsy if risk factors for hyperplasia/cancer.
Menopause hormone therapy: For bothersome vasomotor symptoms in appropriate candidates; weigh VTE, stroke, and breast cancer risks.
Pelvic inflammatory disease: Treat empirically (ceftriaxone + doxycycline ± metronidazole) to preserve fertility; low threshold to treat.
PCOS management: Lifestyle, combined oral contraceptives for cycle/androgen control, and metformin/letrozole for metabolic/fertility goals.
Gout acute flare: NSAIDs, colchicine, or corticosteroids; do not start or stop urate-lowering therapy during an acute flare.
Gout chronic management: Urate-lowering therapy (allopurinol) for recurrent attacks, tophi, or stones; titrate to target urate.
Rheumatoid arthritis: Symmetric small-joint inflammation; start a DMARD (methotrexate) early to prevent joint destruction.
Systemic lupus erythematosus: Multisystem autoimmune disease; hydroxychloroquine for most; immunosuppression for organ involvement.
Polymyalgia rheumatica vs giant cell arteritis: PMR: shoulder/hip stiffness, low-dose steroids. GCA: headache/vision loss, HIGH-dose steroids urgently to save vision.
Low back pain (no red flags): Conservative care and activity as tolerated; imaging only with red flags (neuro deficit, cancer, infection, trauma).
Cauda equina syndrome: Saddle anesthesia, urinary retention, bilateral leg weakness; emergent MRI and surgical decompression.
Osteoarthritis management: Exercise, weight loss, topical/oral NSAIDs and acetaminophen; joint replacement for refractory disease.
Septic vs gout vs RA joint fluid: Septic: very high WBC, positive culture. Gout: negatively birefringent needle crystals. Pseudogout: positively birefringent rhomboids.
Cellulitis: Treat with antibiotics covering streptococci and S. aureus; mark borders and reassess; rule out abscess (needs drainage).
Stevens-Johnson syndrome / TEN: Drug reaction with mucosal involvement and skin sloughing; stop the drug, supportive (burn-unit) care.
Melanoma ABCDE: Asymmetry, Border irregularity, Color variation, Diameter >6 mm, Evolving; biopsy suspicious lesions.
Basal vs squamous cell carcinoma: BCC: pearly papule with telangiectasias (most common). SCC: scaly/ulcerated, can metastasize; both UV-related.
Psoriasis treatment: Topical corticosteroids and vitamin D analogs; phototherapy or systemic/biologic agents for extensive disease.
Cluster headache: Severe unilateral periorbital pain with autonomic signs; acute: high-flow oxygen and triptans.
Vertigo (peripheral vs central): Peripheral (BPPV, vestibular neuritis) is benign; central (stroke) has neuro signs — image if central features.
Carpal tunnel syndrome: Median nerve compression; nocturnal hand numbness; splinting first, then steroid injection or surgery.
Subarachnoid hemorrhage: Thunderclap headache; non-contrast CT, then LP if CT negative; neurosurgical/neuro-IR management.
Erectile dysfunction workup: Can be an early marker of cardiovascular disease; assess risk factors; PDE5 inhibitors (avoid with nitrates).
Refeeding syndrome: Insulin-driven shift of phosphate, potassium, and magnesium into cells when feeding a malnourished patient; can cause arrhythmias.
Refeeding syndrome prevention: Start low calories (about 10-20 kcal/kg/day), advance slowly, and monitor/replace electrolytes (especially phosphate).
Most feared refeeding electrolyte: Hypophosphatemia — replace phosphate before and during feeding.
Thiamine (B1) deficiency: Wernicke-Korsakoff and wet beriberi (high-output heart failure); give thiamine before glucose in at-risk patients.
Vitamin B12 deficiency: Macrocytic anemia with neurologic signs (subacute combined degeneration); check methylmalonic acid; replace B12.
Folate deficiency: Macrocytic anemia WITHOUT neurologic signs; common in alcohol use and pregnancy.
Vitamin D deficiency: Causes osteomalacia/rickets and secondary hyperparathyroidism; supplement with vitamin D and calcium.
Vitamin A deficiency: Night blindness and xerophthalmia; excess is teratogenic and causes pseudotumor cerebri.
Vitamin C deficiency (scurvy): Poor wound healing, bleeding gums, perifollicular hemorrhage; treat with vitamin C.
Vitamin K deficiency: Elevated PT/INR and bleeding; common in malabsorption and newborns (give vitamin K at birth).
Niacin (B3) deficiency (pellagra): The 3 Ds: dermatitis, diarrhea, dementia.
Zinc deficiency: Poor wound healing, dysgeusia, alopecia, and a perioral/acral rash.
Enteral vs parenteral nutrition: Prefer enteral when the gut works ('if the gut works, use it'); parenteral nutrition for nonfunctional GI tracts.
Malnutrition screening in hospital: Identify at-risk patients (poor intake, weight loss, chronic disease); involve dietitians and prevent refeeding syndrome.
Obesity management: Lifestyle first; add pharmacotherapy (GLP-1 agonists) or bariatric surgery based on BMI and comorbidities.
Colorectal cancer screening start age: Age 45 for average-risk adults (USPSTF), continuing through 75; options include colonoscopy or stool-based tests.
Positive stool-based CRC test: Proceed to colonoscopy — a positive FIT or stool DNA test requires diagnostic colonoscopy.
Breast cancer screening: Mammography; USPSTF recommends starting at age 40 (biennial) for average-risk women.
Cervical cancer screening interval: Age 21-29 cytology every 3 years; age 30-65 co-testing or HPV testing per guidelines.
Lung cancer screening: Annual low-dose CT for adults 50-80 with a 20 pack-year history who currently smoke or quit within 15 years.
Abdominal aortic aneurysm screening: One-time ultrasound for men 65-75 who have ever smoked.
Osteoporosis screening: DXA scan in women 65+ (and younger postmenopausal women with risk factors).
Adult immunization staples: Annual influenza; Tdap/Td booster; COVID-19 per guidance; check the current CDC schedule each year.
Pneumococcal vaccination: Recommended for adults 65+ and younger adults with certain conditions; follow the current CDC schedule.
Shingles (zoster) vaccine: Recombinant zoster vaccine for adults 50+ (two doses).
HPV vaccination: Routine at ages 11-12, catch-up through 26 (and shared decision-making through 45).
Live vaccine cautions: Avoid live vaccines (MMR, varicella) in pregnancy and significant immunocompromise.
Tobacco cessation counseling: Use the 5 A's (Ask, Advise, Assess, Assist, Arrange); offer pharmacotherapy plus counseling at every visit.
Alcohol screening: Screen with validated tools (AUDIT-C); provide brief intervention for unhealthy use.
Diabetes screening (USPSTF): Screen adults 35-70 who are overweight or obese for prediabetes and type 2 diabetes.
Hypertension screening: Screen adults 18+ with office BP, confirming with out-of-office measurement before diagnosis.
Depression screening: Screen all adults (and adolescents) with a validated tool such as the PHQ-9 when systems support follow-up.
Statin primary prevention (USPSTF): Adults 40-75 with ≥1 risk factor and a 10-year ASCVD risk of 10% or more (selectively at 7.5-10%).
Health maintenance at every visit: Update screening, immunizations, and counseling — a core continued-care management task on Step 3.
Folate fortification rationale: Reduces neural tube defects at the population level; individual supplementation before conception adds further protection.

To find us again, just search “Career Employer USMLE Step 3”

By Career EmployerUpdated Jun 19, 2026

300+ free USMLE Step 3 flashcards — 4 ways to study

USMLE Step 3 Flashcard of the DayNew daily

The classic card. Do you know this one?

Click Study Flashcards above to open the flashcard hub — hundreds of USMLE Step 3 cards you can flip, match, type, or quiz yourself on. Every card is drawn from what the final step tests — patient management, biostatistics, ethics, and the CCS format — so you study exactly what the exam measures.^[1] Pair them with our free practice questions and study guide.

USMLE Step 3 Flashcard Study Modes

Most flashcard sites give you one thing: a card to flip. Ours has four modes so you can both learn the material and prove you know it — the difference between recognizing an answer and recalling it under pressure.

Flip (Study) — the classic card. Flip term ↔ definition, shuffle the deck, and mark each card “Got it” or “Still learning.”
Match (Game) — a timed game: pair each term to its definition as fast as you can. Great for cementing rule sets like drug monitoring and the sepsis bundle.
Type (Recall) — read the definition and type the term. Typing forces true active recall instead of passive recognition.
Quiz (Test) — multiple-choice questions generated from the cards, so you can self-test exactly like exam day.

Free USMLE Step 3 flashcards from Career Employer — active recall for the final medical licensing exam

Why Flashcards Work for USMLE Step 3

Flashcards aren’t busywork — they’re built on active recall: pulling an answer out of memory strengthens it far more than re-reading notes. Pair that with spacing — short sessions across several days rather than one cram — and you retain more in less time.

On Step 3, that turns the rule-based facts (first-line therapies, drug monitoring, screening ages, the sepsis and DKA protocols) into instant recall, freeing your effort for the clinical judgment the exam actually rewards. Used alongside our practice questions and study guide, flashcards turn review time into measurable progress.

USMLE Step 3 Flashcards by Topic

The cards are organized by what Step 3 tests. Patient management is the heart of the exam, so weight your time there — but the rule-based facts in every area (drug monitoring, screening intervals, ethics principles, the acute-care protocols) are pure recall and reliable points:^[1]

USMLE Step 3 flashcard topics and what they cover
Flashcard topic	What it covers on Step 3
Exam Structure & CCS	The 2-day FIP/ACM format, three-digit scoring, the case simulations
Biostatistics & the Medical Literature	Sensitivity/specificity, predictive values, NNT, study design
Ethics, Communication & Patient Safety	Informed consent, capacity, the four principles, error disclosure
Cardiovascular & Respiratory Management	Hypertension, atrial fibrillation, heart failure, COPD/asthma
Renal, Endocrine & GI Management	Diabetes, thyroid, electrolytes, GI bleeding and liver disease
Acute & Multisystem Emergencies	Sepsis, DKA, anaphylaxis, ACS — the time-critical first action
Neuro, Psych, OB/GYN, MSK & Derm	Stroke, depression, prenatal care, joint disease, skin cancers
Nutrition & Health Maintenance	Deficiencies, refeeding syndrome, screening, immunizations

Because the rule-based associations are so reliably tested, they are some of the most efficient points you can bank with flashcards — leaving your study time for the management reasoning the exam rewards most.

How to Get the Most Out of These Flashcards

Start early, review daily. A few minutes a day beats one marathon session — and Step 3 prep often happens around a busy residency schedule.
Use Type and Quiz, not just Flip. Recognizing the right answer is easy; recalling and choosing it is the real test.
Drill your weakest area. Pick a single deck and grind it until the Match time drops and the Quiz score climbs.
Bank the rule sets. Drug monitoring, screening ages, the sepsis bundle, and the ethics principles are guaranteed points — master them cold.
Think management. When a card describes a patient, the answer is usually the best next step or the first-line therapy, not just the diagnosis.
Then prove it. When the cards feel easy, confirm with our practice questions — build a comfortable margin before exam day.

USMLE Step 3 Flashcards FAQ

Hundreds of free USMLE Step 3 flashcards, spanning what the final step actually tests — patient management and therapeutics, biostatistics and the medical literature, ethics and patient safety, the CCS format, and high-yield clinical content across every organ system. They're free with no account required.

References

1.USMLE Program (FSMB and NBME). “Step 3 Exam Content.” usmle.org. ↑
2.USMLE Program (FSMB and NBME). “Step 3 Overview.” usmle.org. ↑
3.USMLE Program (FSMB and NBME). “Computer-based Case Simulations.” usmle.org. ↑

Career Employer

Career Employer is the ultimate resource to help you get started working the job of your dreams. We cover topics from general career information, career searching, exam preparation with free study materials, career interviewing, and becoming successful in your career of choice.

All Posts

Career Employer’s Editorial Process

Here at Career Employer, we focus a lot on providing factually accurate information that is always up to date. We strive to provide correct information using strict editorial processes, article editing, and fact-checking for all of the information found on our website. We only utilize trustworthy and relevant resources. To find out more, make sure to read our full editorial process page here.